MedPath
FDA Approval

Lisinopril and Hydrochlorothiazide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
LUPIN LIMITED
DUNS: 675923163
Effective Date
May 9, 2016
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hydrochlorothiazide(25 mg in 1 1)
Lisinopril(20 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

LUPIN LIMITED

675923163

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

LUPIN LIMITED

LUPIN LIMITED

LUPIN LIMITED

863645527

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lisinopril and Hydrochlorothiazide

Product Details

NDC Product Code
57297-520
Application Number
ANDA077912
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 9, 2016
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: 0J48LPH2THClass: ACTIBQuantity: 25 mg in 1 1
Code: E7199S1YWRClass: ACTIBQuantity: 20 mg in 1 1
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
© Copyright 2025. All Rights Reserved by MedPath